The COVID Project
The record
- Jurisdiction
- United States (federal); Department of Health and Human Services, Office of the Secretary
- Level
- Federal
- Authority
- FD&C Act s. 564(b)(1)(C)
- Issued
- 2020-02-04 Feb. 4, 2020
- Effective
- 2020-02-04
- End
- In force throughout 2020-2021 (read as 2021-09-30)
- In force
- Feb. 4, 2020 to Sept. 30, 2021
- Quarters
- 2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3
2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3
- Limitation types
- Emergency declarationSupply chain
- Addressees
- FDA; test developers and laboratories
- Functions reached
- DX diagnostics
- SC supply chain
- Collection
- Other federal health agencies AGY-FED-HEALTH-OTHER
Operative words
I declared that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of the novel coronavirus (2019-nCoV) pursuant to section 564 of the FD&C Act, subject to the terms of any authorization issued under that section.... DATES: The determination and declaration took effect February 4, 2020.
Enforcement
Notes
The first federal COVID-19 emergency instrument after the section 319 declaration.